The Health Industry Forum held a conference yesterday: Shaping Convergent Strategies in Comparative Effectiveness Research. Sara Hansard at BNA reports that Douglas Hadley, director of CIGNA's coverage policy unit, said that while costs should not be an initial goal of comparative effectiveness research, they should be considered if treatment outcomes prove to be identical.
To be sure, the primary stated purpose of PPACA's Patient-Centered Outcomes Research Institute is the improve health outcomes. But Gail Wilensky, a senior fellow with international health foundation Project HOPE, said "there is an important secondary purpose, which is regarding comparative effectiveness research as a building block in learning how to spend smarter."
Tidak ada komentar:
Posting Komentar